Related Experiment Videos
The endothelial protein C receptor
1Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma, USA. charles-esmon@omrf.ouhsc.edu
Current Opinion in Hematology
|August 5, 2006
Summary
Genetic and acquired abnormalities in the endothelial cell protein C receptor (EPCR) are linked to thrombotic disease. Understanding EPCR genotype and auto-antibodies can help diagnose thrombotic event risk.
Area of Science:
- Biochemistry
- Immunology
- Hematology
Background:
- The endothelial cell protein C receptor (EPCR) is vital for activated protein C's anticoagulant, anti-inflammatory, and anti-apoptotic functions.
- Dysregulation of EPCR may predispose individuals to thrombosis and heightened inflammatory responses during infection.
Purpose of the Study:
- To review recent evidence linking endothelial cell protein C receptor abnormalities to pathophysiological disease processes.
- To explore the role of EPCR in thrombotic tendencies and inflammatory conditions.
Main Methods:
- Review of recent scientific literature and evidence.
- Analysis of studies involving genetic polymorphisms and acquired abnormalities of EPCR.
- Examination of data from mouse models and human clinical studies.
Main Results:
- Modulation of coagulation and inflammatory processes by altered EPCR expression in mice.
- Association of genetic polymorphisms with changes in EPCR protein levels.
- Link between EPCR abnormalities and familial/acquired thrombotic diseases.
Conclusions:
- Emerging clinical data implicate EPCR in thrombotic disease.
- EPCR genotype and auto-antibody status may assist in diagnosing thrombotic risk.
- Further research into EPCR's role can improve patient risk stratification for thrombotic events.